推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Stent Thrombosis: Did Biodegradable Polymers Fail or Are We Too Impatient?

P Salinas, R Moreno… - Journal of the …, 2011 - Am Coll Cardio Found
... for Restenosis II], ISAR-TEST-3 [Intra- coronary Stenting and Angiographic Results: Test Efficacy
of Rapamycin-Eluting Stents With Different Polymer Coating Strat- egies], ISAR-TEST-4
[Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents ...

Kounis Syndrome Should Be Considered the Culprit Cause of the Most Feared Stent Thrombosis

NG Kounis - Journal of the American College of Cardiology, 2011 - Am Coll Cardio Found
... for Restenosis II], ISAR-TEST-3 [Intra- coronary Stenting and Angiographic Results: Test Efficacy
of Rapamycin-Eluting Stents With Different Polymer Coating Strat- egies], ISAR-TEST-4
[Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents ...

Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel-and sirolimus-eluting stent in patients undergoing percutaneous coronary …

S Cassese, R Piccolo, G Galasso… - International Journal of …, 2011 - Elsevier
... The Breslow–Day chi-squared test was calculated to test the statistical evidence of heterogeneity
across the studies. ... The Harbord test is a modified version of Egger test and has a type I error close
to the nominal level in the absence of between-study heterogeneity. ...
Cited by 1 - Related articles - All 2 versions

Polymer-Free Sirolimus-and Probucol-Eluting Versus New Generation Zotarolimus-Eluting Stents in Coronary Artery DiseaseClinical Perspective

S Massberg, RA Byrne, A Kastrati, S Schulz… - Circulation, 2011 - Am Heart Assoc
... The Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and
Probucol-Eluting Versus Zotarolimus-Eluting Stents (ISAR-TEST 5) Trial. ... Data distribution was
tested for normality using the Kolmogorov-Smirnov test for goodness of fit. ...
Cited by 1

[HTML] Advantages and disadvantages of biodegradable platforms in drug eluting stents

[HTML] from nih.govA Rodriguez-Granillo, B Rubilar… - World Journal of …, 2011 - ncbi.nlm.nih.gov
... paragraphs we will review and summarize the main findings from published randomized data
of the Limus Eluted from a Durable vs Erodable Stent Coating (LEADERS)[28], NOBORI[33,34],
Individualized Drug Eluting Stent System to Abrogate Restenosis (ISAR)-TEST-3[35 ...
Related articles - All 7 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451